Dahl, L.O.S.; Hak, S.; Braaen, S.; Molska, A.; Rodà , F.; Parot, J.; Wessel, Ø.; Fosse, J.H.; Bjørgen, H.; Borgos, S.E.;
et al. Implementation of mRNA–Lipid Nanoparticle Technology in Atlantic Salmon (Salmo salar). Vaccines 2024, 12, 788.
https://doi.org/10.3390/vaccines12070788
AMA Style
Dahl LOS, Hak S, Braaen S, Molska A, Rodà F, Parot J, Wessel Ø, Fosse JH, Bjørgen H, Borgos SE,
et al. Implementation of mRNA–Lipid Nanoparticle Technology in Atlantic Salmon (Salmo salar). Vaccines. 2024; 12(7):788.
https://doi.org/10.3390/vaccines12070788
Chicago/Turabian Style
Dahl, Lars Ole Sti, Sjoerd Hak, Stine Braaen, Alicja Molska, Francesca Rodà , Jeremie Parot, Øystein Wessel, Johanna Hol Fosse, Håvard Bjørgen, Sven Even Borgos,
and et al. 2024. "Implementation of mRNA–Lipid Nanoparticle Technology in Atlantic Salmon (Salmo salar)" Vaccines 12, no. 7: 788.
https://doi.org/10.3390/vaccines12070788
APA Style
Dahl, L. O. S., Hak, S., Braaen, S., Molska, A., Rodà , F., Parot, J., Wessel, Ø., Fosse, J. H., Bjørgen, H., Borgos, S. E., & Rimstad, E.
(2024). Implementation of mRNA–Lipid Nanoparticle Technology in Atlantic Salmon (Salmo salar). Vaccines, 12(7), 788.
https://doi.org/10.3390/vaccines12070788
